期刊文献+

临床护理路径结合PDCA循环在弥漫大B细胞淋巴瘤化疗患者中的应用 被引量:11

Application of clinical nursing pathway combined with PDCA cycle in chemotherapy patients with diffuse large B cell lymphoma
下载PDF
导出
摘要 目的探讨临床护理路径结合PDCA循环在弥漫大B细胞淋巴瘤患者化疗中的应用效果。方法将160例行化疗的DLBCL患者按入院时间顺序分为2组,对照组80例运用化疗常规工作模式,实验组80例实施临床护理路径结合PDCA循环。比较2组患者健康教育知晓度、对护士工作满意度、不良反应发生情况和平均住院日情况。结果实验组患者健康教育知晓度和对护士工作满意度优于对照组(P<0.05),实验组患者治疗期间不良反应发生情况、平均住院日少于对照组(P<0.05)。结论应用临床护理路径结合PDCA循环的标准化管理,可增加患者对疾病的认知能力,提升专科护理质量,提高工作效率和满意度。 Objective To explore the application of clinical nursing pathway combined with PDCA cycle in chemotherapy patients with diffuse large B cell lymphoma(DLBCL). Methods 160 chemotherapy patients with DLBCL were divided into experimental group and control group, with 80 patients in each group. Patients in the control group were given the conventional chemotherapy and patients in the experimental group were given clinical nursing pathway combined with PDCA cycle. Health education, iob satisfaction, the occurrence of adverse reactions and the average hospitalization days were compared between the two groups. Results The awareness of health education and job satisfaction in experimental group were better than that in the control group(P 〈 0.05). The occurrence of adverse reactions and the average hospitalization days in ex- perimental group were lower than that of control group (P 〈 0.05). Conclusion The standard- ized management of clinical nursing pathway combined with PDCA cycle can increase the cognitive ability for diseases and improve the work efficiency as well as satisfaction.
出处 《实用临床医药杂志》 CAS 2014年第8期17-19,共3页 Journal of Clinical Medicine in Practice
基金 江苏省南通市社会事业科技创新与示范计划项目(HS12946)
关键词 弥漫大B细胞淋巴瘤 化疗 临床护理路径 循环管理 diffuse large B cell lymphoma chemotherapy clinical nursing pathway cy-cle management
  • 相关文献

参考文献11

二级参考文献90

共引文献361

同被引文献78

  • 1谌海兰.利妥昔单克隆抗体联合CHOP方案治疗高龄非霍奇金淋巴瘤患者的疗效[J].中国老年学杂志,2014,34(12):3264-3266. 被引量:9
  • 2Martelli M,Ferrei A J.Diffuse large B-cell lymphoma[J].Crit Rev Oncol Hematol,2013,87(2):146.
  • 3Tilly H,Vitolo U,Walewski J,et al.Diffuse large B-cell non-Hodgkin’s lymphoma:ESMO clinical practice guidelines for diagnoseis,treatment and follow-up[J].Ann Oncol,2012,23(suppl7):78.
  • 4Farzaneh Foroughinia,Shadi Baniasadi,Sharareh Seifi.Vincristine-Induced Seizure Potentiated by Itraconazole Following RCHOP Chemotherapy for Diffuse Large B-Cell Lymphoma[J].Current Drug Safety,2012,7(5):372.
  • 5Brigita Gregoric,Vesna Zadnik,Barbara Novakovic.The diffuse large B-cell lymphoma-where do we stand now in everyday clinical practice[J].Radiology and Oncology,2012,46(2):153.
  • 6William H Porr,Jonathan L Henderson,Michael J Morris.Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall[J].Current Respiratory Medicine Reviews,2013,9(2):75.
  • 7Agata Majchrzak,Magdalena Witkowska,Piotr Smolewski.Inhibition of the PI3K/Akt/m TOR Signaling Pathway in Diffuse Large B-Cell Lymphoma:Current Knowledge and Clinical Significance[J].Molecules,2014,19(9):14304.
  • 8RI Fisher,TP Miller,OA O'Connor.Diffuse aggressive lymphoma[J].Hematology,2004(1):221.
  • 9程秀红,陈小云.1例髋关节离断术后切口及半骨盆严重感染患者的护理[J].中华护理杂志,2009,44(2):137-139. 被引量:10
  • 10张瑞春,金爽,廖丽昇.美罗华联合化疗治疗弥漫大B细胞淋巴瘤21例护理[J].齐鲁护理杂志,2010,16(3):54-55. 被引量:3

引证文献11

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部